Concepedia

S. Welten

SW

10

Publications

471

Citations

10

H-Index

2012

Active since

Affiliations

Leiden University Medical Center(Current)

Leiden University

Idera Pharmaceuticals (United States)

Amsterdam UMC Location Vrije Universiteit Amsterdam

Odense University Hospital

S. Welten is an author at Leiden University Medical Center specializing in gene expression, cancer research, and functional genomics.

Top concepts

Publications per year

2012–2018

10

Publications

10

Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 Increases Neovascularization and Blood Flow Recovery After Ischemia

S. Welten, A.J.N.M. Bastiaansen, Rob C. M. de Jong et al. · Circulation Research · 2014 · 141 citations

Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis

A.J.N.M. Bastiaansen, M.M. Ewing, Hetty C. de Boer et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 62 citations · Full text

The 14q32 MicroRNA-487b Targets the Antiapoptotic Insulin Receptor Substrate 1 in Hypertension-Induced Remodeling of the Aorta

A. Yaël Nossent, Tilde Eskildsen, Lene B. Andersen et al. · Annals of Surgery · 2013 · 43 citations

Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics

Carlota Oleaga, S. Welten, A Belloc et al. · Biochemical Pharmacology · 2012 · 43 citations

, , +11

Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability

Anouk Wezel, S. Welten, Wida Razawy et al. · Annals of Surgery · 2015 · 43 citations

Rows per page

1–5 of 10